NPI Details
BIODESIX, INC. is a clinical medical laboratory in De Soto, KS. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. BIODESIX, INC. NPI is 1639713787. The provider is registered as an organization entity type.
The provider's business location address is:
8960 COMMERCE DR BLDG 6
DE SOTO, KS
ZIP 66018-433
Phone: (913) 583-9000
Fax: (913) 583-9001
The provider's authorized official is Robin Harper Cowie .
The authorized official title is Chief Financial Officer and has the following contact phone number (720) 509-8841.
The CLIA number assigned to this NPI record is 17D1089651 - ancillary testing site in health care center with a certificate type of Certificate of Accreditation.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Multianalyte assay procedure with algorithmic analysis (HCPCS:81599)
- Analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein m130 in plasma, with clinical risk factors, to evaluate probability of lung cancer (HCPCS:0080U)
The enumeration date for this NPI number is 11/1/2019 and was last updated on 2/20/2020.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | | | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 17D1089651 | OTHER | KANSAS | CLIA |
